Facebook
Twitter
LinkedIn
ForwardAnti-Epileptic Medications
This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and earn a 70% or higher score on the post test will be awarded 1 NAPNAP contact hour, of which 1.0 is pharmacology.
IMPORTANT: This continuing education activity is offered at a reduced rate to NAPNAP Members. You must be logged in using your NAPNAP Username and Password to be recognized as a Member of NAPNAP. If you are a current member of NAPNAP, and you are being asked to purchase this activity at the Non-Member rate, please contact the NAPNAP National Office at (877) 662-7627 to request assistance prior to entering any payment information.
Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: ce@napnap.org
Copyright 2018 © by National Association of Pediatric Nurse Practitioners (NAPNAP)
Keywords: seizures, epilepsy, anti-epileptic medications
Target Audience
Pediatric-focused advanced practice registered nurses
Learning Objectives
• Review the history of seizure treatment and discuss this evolution based on drug action and efficacy.
• Describe the mechanism of action of the newest anti-seizure medication and compare these drugs to those previously prescribed.
• Identify the most effective, evidence-based anti-epileptic drugs and list potential side effects of the older and newest therapies.
Catherine Haut, DNP, CPNP-AC-PC, CCRN, FAANP: Nurse Practitioner, Beacon Pediatrics, Rehoboth Beach, Del.; Research Director, Nemours/Alfred I. duPont Hospital for Children, Wilmington, Del.
Disclosures:
There are no disclosures to report for Catherine Haut.
Available Credit
- 1.00 Contact hours